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Patients with multiple myeloma, Hodgkin's disease and other 
lymphomas have gamma globulin peaks in their serum electrophoretic 
pattern much above normal; usually, they also have histories of 
repeated infections, as well as poor antibody response to specific 
antigens. High serum gamma globulin levels have been noted by some 
investigators in patients with a variety of diseases associated with 
chronic infections— including certain chest diseases. The present 
study consisting of 254 patients and forty-one controls, showed a 
statistically significant elevation of the serum gamma globulin 
levels in patients with tuberculosis (active or inactive), bronchiectasis 
chronic bronchitis, and the infectious type of asthma. On the other 
hand, patients with allergic asthma or with mixed-type asthma had 
gamma globulin levels within the normal range.
Since some of the patient subjects had high serum gamma globulin 
levels, it was hypothesized that they might show (as do patients with 
multiple myeloma, Hodgkin's disease, and other lymphomas) poor anti­
body response to specific antigens. In order to test this hypothesis, 
a controlled study was undertaken in which eleven patients with chronic 
bronchitis and a history in common of repeated respiratory infections 
and five "normal control subjects" were immunized with diphtheria 
toxoid, staphage lysate, mumps, influenza, and typhoid-paratyphoid 
vaccines. Although incomplete, the results obtained from this small
series of patients suggest that a factor other than antibody response 
seems to play an important role in the increased susceptibility of 
these patients to infections.
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INTRODUCTION
The simplicity of the technique of paper electrophoresis (l-3), when 
compared with the classic Tiselius technique has led to its wider
application in the separation and measurement of the various protein 
fractions of serum and plasma. For the past five years serum electro­
phoretic studies have been done routinely on all patients admitted to 
the chest service of the National Jewish Hospital at Denver. The pur­
poses of this thesis are to discuss the data obtained from the various 
patient groups, and to review the literature relating to the general use 
and clinical application of the serum electrophoresis technique, with 
particular emphasis on the role of serum electrophoresis in the pulmonary 
diseases.
A study of the antibody response to specific antigens was attempted 
in a few patients with a clinical diagnosis of chronic bronchitis.
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Serum electrophoretic studies were done on 295 adults. (Table I)
The patients ranged in age from l6 through 75 years. For this study they 
were divided into eight groups: active pulmonary tuberculosis, 135 
(Appendix A); inactive pulmonary tuberculosis, (Appendix B); chronic 
bronchitis, 14 (Appendix C); bronchiectasis, 12 (Appendix D)} infectious 
asthma, 10 (Appendix E)} allergic asthma, 20 (Appendix F)j and asthma, 
mixed type (allergic and infectious components), 29 (Appendix G). All 
forty-one subjects used as controls (Appendix H) had normal chest x-ray 
films and no histories of known chest disease.
Assignment of a patient to a clinical group was based on a thorough 
study, including history, chest x-rays, sputum studies, and, if indi­
cated, bronchoscopy, bronchograms, skin, conjunctival and inhalation 
tests*
Patients with active tuberculosis, regardless of extent of disease, 
were put into one group} patients with inactive tuberculosis, into a 
second group.
Patients in the chronic bronchitis group were those with recurrent, 
long-standing, low-grade infection of the respiratory tract, producing 
yellow or yellowish-green sputum, with or without fever.
Patients in the bronchiectasis group were assigned to it on the 
basis of bronchographic confirmation.
Patients put in the bronchial asthma group were those who had
MATERIAL
3recurrent attacks of wheezing, cough and shortness of breath. A thor­
ough cause-and-effect history of the patient, allergy skin tests, and 
conjunctival and inhalation tests were evaluated in order to differen­
tiate the allergic from the infectious and the mixed type of asthma.
Any classification is bound to provoke controversy; however, to avoid 
confusion, "asthma" was divided into these three categories: infectious, 
allergic, and mixed type.
table I
DISTRIBUTION OF PATIENTS
Pulmonary Tuberculosis, Active 135
Pulmonary Tuberculosis, Inactive 3^
Chronic Bronchitis Ik
Bronchiectasis 12
Bronchial Asthma (infectious) 10
Bronchial Asthma (Allergic) 20
Bronchial Asthma (Mixed) 29
Total 251+
Controls J a
Grand Total 295
METHOD
Venous blood was drawn before breakfast and allowed to clot at room 
temperature. The tubes containing the clotted blood were centrifuged 
at low speeds, and the clear unhemolyzed sera were decanted. Whenever 
possible, the electrophoretic patterns were run the same day. If not, 
the sera were kept in liquid state at 0° to 2°C. Approximately two ml. 
of serum was required for each electrophoretic analysis.
These analyses were made with the Spinco Model R Paper Electro­
phoresis System. (8) Ten microliters (0.01 ml.) of serum was applied to 
a three-millimeter Whatman paper strip suspended in the electrophoresis 
cell vessel containing barbital buffer (pH 8.6). A constant output 
rectifier supplied five milliamperes of current to the cell vessel for 
16 hours at room temperature. The electrophoretic patterns so obtained 
were dried for 30 minutes in an oven preheated to between 120° and 
130°c. The strips were then stained with bromphenol blue and zinc sul­
fate and fixed with sodium acetate. The stained strips were scanned by 
means of a Spinco Analytrol, which is a conbined scanner and integrator, 
and the per cent distribution of the protein was calculated. Serum 
total proteins were determined by the biuret method. (9)
The different fractions of the total protein were converted into 
grams/lOO ml., and the mean standard deviation and the mean standard 
error for each of the eight groups computed. The T-test for unpaired 
variates was used to evaluate the differences between each of the seven
disease groups and the control group1. If the probability (P value) was 
greater than 0.05, no significant difference between the different groups 
was assumed. A probability (P value) of less than 0.05 was interpreted 
to mean that a statistically significant difference existed.
17— Volk, william. Applied Statistics for Engineers.N. Y., McGraw-Hill 
Book Co., Inc., pp. 115— 116, 1958.
RESULTS
Serum Total Proteins
In 29 cases of bronchial asthma (mixed type), a statistically 
significant decrease of serum total proteins was noted when this group 
was compared with the control group. A borderline decrease of serum 
total proteins was noted in fourteen patients with chronic bronchitis. 
No significant change was noticed in patients belonging to the other 
groups studied when compared with the control group. (Table II)
Serum Albumin
Significant reduction of serum albumin was noticed in cases of 
active and inactive pulmonary tuberculosis, and chronic bronchitis when 
compared with the control group. There was borderline reduction in 
cases of bronchiectasis and bronchial asthma (mixed type). No signifi­
cant difference was found between the disease and the control groups 
in cases of bronchial asthma of the allergic and the infectious types. 
(Table III)
Alpha-1 Globulin
No statistically significant changes were noticed in any of the 
groups when compared with the control group. (Table IV)
Alpha-2 Globulin
No statistically significant changes were found in any of the 
seven groups when compared with the control group. (Table V)
8Beta Globulin
No statistically significant difference was noticed in any of the
seven groups when compared with the control group. (Table VI)
, - (
Gamma Globulin
There was a marked and statistically significant rise of gamma 
globulin in cases of bronchiectasis when compared with the control 
group. Statistically significant elevations of gamma globulin levels 
were also noticed in cases of active and inactive pulmonary tuberculosis, 
chronic bronchitis, and asthma of infectious type. Cases of the 
allergic and mixed type of asthma showed no statistically significant 
changes in the gamma globulin levels. (Table VII)
TABLE II
THE SERUM PROTEIN LEVEL IN EACH GROUP AS COMPARED TO THE CONTROL GROUP
Number Standard
of Msan Deviation Significance
Cases (Gm/lOOcc) (£) (P )*
Pulmonary Tbc., Active 135 7.51 0.76 P > 0.1
Pulmonary Tbc., Inactive 3^ 7.39 0.53 P > 0.05
Chronic Bronchitis lb 7.12 1.01 P < 0.05
Bronchiectasis 12 7.33 0.59 P > 0.1
Bronchial Asthma (inf.) 10 7.35 0.66 P = 0.2
Bronchial Asthma (Allergic) 20 7.^5 0.86 P > 0.2
Bronchial Asthma (Mixed) 29 7.06 0.92 P < 0.001
Controls 4l
HI
7.69 0.76
* P value < 0.05 shows a significant difference between the groups
- compared.
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TABLE III
THE SERUM ALBUMEN LEVEL IN EACH GROUP COMPARED TO THE CONTROL GROUP
Number
of
Cases
Mean
(Gm/lOOcc)
Standard
Deviation
(±)
Significance
(P)*
Pulmonary Tbc., Active 135 3.28 l.kQ P < 0.001
Pulmonary Tbc., Inactive 31*- 3.63 0.80 P < 0.02
Chronic Bronchitis Ik 3 . H 1.02 P < 0.01
Bronchiectasis 12 3.38 1.32 P > 0.05
Bronchial Asthma (Inf.) 10 3.55 1.3^ P > 0.2'
Bronchial Asthma (Allergic) 20 3.98 1.06 P > 0.3
Bronchial Asthma (Mixed) 29 3.72 0.93 P > 0.05
Controls hi
295
^.33 O .98
* P value < 0.05 shows a significant difference between the groups
, compared.
TABLE IV
THE SERUM ALPHA-1 GLOBULIN LEVEL IN EACH GROUP
AS COMPARED TO THE CONTROL GROUP
Number
of
Cases
Mean
(Gm/lOOcc)
Standard
Deviation
(i)
Significance
(P)*
Pulmonary Tbc., Active 135 0.2 0.15 P > 0.5
Pulmonary Tbc., Inactive 3^ 0.26 0.11 P > 0.5
Chronic Bronchitis lb 0.28 0.13 P > 0.9
Bronchiectasis 12 0.24 0.11 P > 0.4
Bronchial Asthma (Inf.) 10 0.26 0.14 P > 0.7
Bronchial Asthma (Allergic) 20 0.28 0.13 P > 0.9
Bronchial Asthma (Mixed) 29 0.24 0.09 P > 0.2
Controls -4l
295
0.28 0.1
* P value <0.05 shows a significant difference between the groups
- compared.
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TABLE V
THE SERUM ALPHA-2 GLOBULIN LEVEL IN EACH GROUP 
AS COMPARED TO THE CONTROL GROUP
Number
of
Cases
Mean
(Gm/lOOcc)
Standard
Deviation
(±)
Significance
(P)*
Pulmonary Tbc., Active 135 0.79 0.27 P > 0.4
Pulmonary Tbc., Inactive 3^ 0.73 0.23 P > 0.9
Chronic Bronchitis 14 0.95 0.40 P > 0.2
Bronchiectasis 12 0.78 0.34 P > 0.7
Bronchial Asthma (inf.) 10 0.73 0.33 P > 0.9
Bronchial Asthma (Allergic) 20 O.83 0.41 P > 0.5
Bronchial Asthma (Mixed) 29 0.75 0.24 P > 0.8
Controls hi
295
0.73 0.41
* P value < 0.05 shows a significant difference between the groups
. compared.
TABLE VI
THE SERUM BETA GLOBULIN LEVEL IN EACH GROUP
AS COMPARED TO THE CONTROL GROUP
Nturtoer
of
Cases
Mean
(Gm/lOOcc)
Standard 
Deviation 
(± )
Significance
(F)*
Pulmonary Tbc., Active 135 O .96 0.3k P > 0.4
Pulmonary Tbc., Inactive 3^ 1.10 0.37 p > 0.6
Chronic Bronchitis Ik 1.06 O .38 P > 0.9
Bronchiectasis 12 1.00 0.4-9 P > 0.8
Bronchial Asthma (inf.) 10 1.09 0.44 P > 0.7
Branchial Asthma (Allergic) 20 1.03 0.4l P > 0.9
Bronchial Asthma (Mixed) 29 0.98 0.34 P > 0.6
Controls _4i 1.04 0.35
295
* P value < 0.05 shows a significant difference between the groups
„ compared.
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TABLE VII
THE SERUM GAMMA GLOBULIN LEVEL IN EACH GROUP, 
AS COMPARED TO THE CONTROL GROUP
Nuaber
of
Cases
Mean
(Gm/lOOcc)
Standard
Deviation
(±)
Significance
(P)*
Pulmonary Tbc., Active 135 1.57 0.56 P < 0.02
Pulmonary Tbc., Inactive 3^ 1.62 o.ia P < 0.01
Chronic Bronchitis Ik 1.68 0.66 P < 0.02
Bronchiectasis 12 1.9^ 0.68 P < 0.001
Bronchial Asthma (inf.) 10 1.70 O.lt-2 P < 0.01
Bronchial Asthma (Allergic) 20 1.32 O .33 No significant 
difference
Bronchial Asthma (Mixed) 29 1.26 0.1+0 No significant difference
Controls J a
295
1.33 0.37
* P value < 0,05 shows a significant difference between the groups
_ compared.
REVIEW OF LITERATURE
Seibert and Nelson in 1942 were among the first to report serum 
electrophoretic changes in cases of pulmonary tuberculosis. (10) They 
observed that the elevated gamma globulin level in minimal tuberculosis 
increased as the extent of involvement increased. In far-advanced 
tuberculosis, they noted an increase in all the globulin fractions.
In 1943, the same authors compared the serum protein changes observed 
in human tuberculosis with those observed in rabbits with experimentally 
induced tuberculosis. (11) Sera obtained from the rabbits showed a 
constant decrease in albumin and an increase in beta globulin fractions; 
whereas the human sera revealed a decrease in albumin and an increase 
in alpha and gamma globulin concentrations.
In a separate study, Seibert and others reported an increase in 
the true polysaccharide content of the serum in human tuberculosis. (12) 
The level of this polysaccharide was, to some extent, proportionate to 
the degree of involvement.
Seibert and associates in 1947 correlated the serum protein 
patterns with the extent of tuberculous involvement. In minimally- 
active tuberculosis, they reported a rise in the level of gamma globulin 
fraction and a fall in albumin fraction; in moderately-advanced tuber­
culosis they observed, in addition to the above changes, an increase in 
the alpha-2 globulin fraction. They related the rise in the latter 
fraction to the increased polysaccharide content of the serum. In
16
far-advanced pulmonary tuberculosis they described an increase in all 
the globulin fractions along with a decrease in the albumin concen­
tration. There was, however, no change in the mean total protein. The 
increase in gamma globulin in minimal tuberculosis was attributed to 
antibody formation, whereas the simultaneous rise in alpha-2 globulin 
and polysaccharide in advanced tuberculosis probably represented tissue 
destruction.
In 19^8, Seibert et ai. described a simple method for determining 
the presence of a polysaccharide-like substance in the serum* (14) The 
test was based on a reaction between the tryptophan and the carbohydrate 
complex. A significant rise of the level of this polysaccharide-like 
substance, the exact nature of which is unknown, was found in cases of 
tuberculosis.
Martens and Bunge in 1950 noted an increase in the serum level of 
alpha globulins in exudative tuberculous processes, while a marked rise 
was noted in the coarsely-dispersed globulins (fibrinogen and gamma 
globulin) in the chronic, proliferating, and cirrhotic forms. (15) They 
related a significant increase of the alpha globulin to a progression 
of the disease. On the other hand, a marked increase of the coarsely- 
dispersed proteins, especially gamma globulin, suggested a good defense 
by the host.
Using the Kunkel method (l6), Small in 1950 studied the gamma 
globulin contents of serum in a series of 150 tuberculous patients. (17) 
He failed to confirm Seibert's earlier findings that an increase in 
gamma globulin content usually kept pace with the progress of the 
disease. Instead, he felt that there was considerable overlapping of 
values in the minimal, moderately-, and far-advanced active cases.
According to Small, the hepatotoxic changes described by Mertens and 
Bunge could be related to the use of an antituberculosis drug called 
contaben.
In 1953, Schaffner et al. correlated the serum levels of gamma 
globulin, mucoproteins, and polysaccharides with the histological 
changes found in liver and lymph node biopsy and sternal marrow speci­
mens in twenty-three patients with far-advanced pulmonary tuberculosis. 
(18) A statistically significant correlation was found between the 
level of the serum gamma globulin, total degree of hepatic alteration, 
and the number of plasma cells in the bone marrow. In their opinion, 
the level of serum gamma globulin reflected the severity of the
!.
nonspecific host reactions seen in the liver.
Volk, and associates in 1953 observed that all patients with active 
pulmonary tuberculosis, including those with minimal lesions, showed 
some increase of the gamma globulin. (19) They thought that the 
severity of the disease, as well as the prognosis, could be correlated 
with the changes in the gamma globulin level. The alpha-2 and beta 
globulin levels were not valid prognostic indicators because they 
remained elevated,even in the arrested cases. Serial electrophoretic 
determinations were recommended to monitor the gamma globulin changes.
Baldwin and Hand in 1953 reported an increase in alpha-1, alpha-2, 
and gamma globulin fractions as the tuberculous process progressed. (20) 
These changes were accompanied by a corresponding decrease in the 
aihum-tn concentration of the serum. The same pattern was observed in 
cases of bone and renal tuberculosis. They also demonstrated a 
complement-fixing antibody in the gamma globulin fraction of the sera 
of some patients with advanced pulmonary tuberculosis. When the
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tuberculous serum was absorbed with ttycobacterium tuberculosis, no 
changes were observed in the concentration of this fraction. They 
concluded that increased antibody production was not responsible for 
the rise in gamma globulin.
Kanagami in 1954 studied serum proteins of 122 patients with 
pulmonary tuberculosis who had had no prior chemotherapeutic treat­
ment. (21) Although he observed no correlation between the beta 
globulin and the disease process, he was able to confirm the other 
serum changes, that is, increases in alpha-1, alpha-2, and gamma 
globulins.
Saifer et al. in 1954 studied patients who were undergoing isonia- 
zid therapy, and reported that their serum protein patterns reflected 
the clinical course of the disease. (22) They concluded that this 
technique could be used to evaluate objectively the changing status of 
the tuberculous process.
Matsui and Taraura in 1955 confirmed the correlation of decreased 
albumin with the severity of the disease process. (23) The decrease 
in the beta globulin fraction was greater in the cases of far^advanced 
tuberculosis than in the moderately-advanced cases.
Vannini, Mulargia, and Gelli in 1955 observed a decrease in serum 
albumin and an increase in alpha and gamma globulins in the patients 
subjected to thoracoplasty or extrapleural pneumothorax. (24) In the 
same year, Meyer and co-workers showed that changes in the alpha-2 
globulin level could be correlated with the patient’s status— increasing 
with progression of disease and decreasing with improvement. (25) They 
regarded a persistence or reappearance of an increase of alpha-2 
globulin as of serious prognostic significance.
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In a study involving 327 patients suffering from pulmonary 
tuberculosis and 28 unaffected ’’contacts*' used as controls, Gilliland 
and associates in 1956 observed higher alpha-2 globulin concentrations, 
in the tuberculous group*(26) They thought that the albumin/alpha-2 
ratio was a more sensitive index of tuberculous activity than the 
erythrocyte sedimentation rate. The observations of Gilliland and 
many previous workers were further confirmed by Rawlings et al. in 
1956. (27)
Jencks and co-workers in 1956 studied the serum electrophoretic 
patterns of more than 1500 patients admitted to an arny general 
hospital. (28) According to them, abnormalities of serum protein 
distribution were most frequently associated with infections (particu­
larly tuberculosis), malignant neoplasms, arteriosclerosis, rheumatic 
heart disease, hepatitis, cirrhosis, rheumatoid arthritis, and 
sarcoidosis. Jencks usually noted a decrease in serum albumin, which 
was followed by an elevation of alpha-1, alpha-2, beta an! gamma 
globulins; a rise in the level of albumin and a decrease in the serum
globulin was observed only rarely.
McCuiston and Hudgins in i960 reported that the serum electro­
phoretic changes observed in 7^ cases of pulmonary diseases caused by 
unclassified ftycobacteria (nonphotochramogenic) resenbled those 
observed in sarcoidosis. (29) There was a decrease in serum albumin, 
and an increase in gamma globulin without a concomitant rise in alpha-2
globulin.
Chievitz and Thiede in i960 used the serum electrophoretic tech­
nique to differentiate pulmonary tuberculosis from other wide-spread j 
pulmonary diseases. (30) In their opinion, low serum albumin and high
alpha-2 and gamma globulins indicate tuberculosis; however, the 
comination of low albumin and low gamma globulin tends to exclude the 
diagnosis, even when the alpha-2 globulin is elevated.
In asthma almost all of the studies of serum proteins have been 
done with children. Usually the studies are concerned with the empiri­
cal value of the use of gamma globulin in the treatment of asthma 
associated with repeated respiratory infections. Cooke and others in 
1951 were among the first to study the serum protein patterns in adult 
patients with chronic asthma. (31) They found that four out of nineteen 
patients had an essentially normal albumin/globulin ratio, while the 
remaining fifteen had a hyperglobulinemia which coincided with a 
lowered albumin/globulin ratio. The serum gamma globulin concentration 
was definitely above normal values in four instances, and slightly 
elevated in several others. Elevation of alpha globulin was distinct 
in eight patients, and slightly so in several others. The beta globu­
lin values in twelve patients were within normal range; however, the 
remaining six subjects exhibited a somewhat lower value. In one 
instance, alpha-2 and beta globulins failed to separate during the 
electrophoresis. The sera of the two adult patients whose chronic 
asthma was due entirely to extrinsic causes showed a normal album­
in/globulin ratio. According to these workers, the changes found in 
the serum proteins were not the product of the allergic state per se. 
Since similar alterations of protein distribution were found in 
nonallergic infections such as osteomyelitis and bronchiectasis, these 
changes appeared to be related directly or indirectly to the chronic 
underlying infection.
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Rose and associates In 1956 studied the serum proteins in a number 
of different diseases, including asthma, urticaria, periarteritis 
nodosa, penicillin reactions, serum sickness, erythema nodosum, and 
lupus erythematosus disseminatus. (32) They found nothing of any conse- 
quence in the clear-cut cases of allergy: the changes in serum proteins,
if any, were entirely nonspecific. (33)
Ferri et. al. in 1956 used the paper electrophoretic technique to 
study 44 samples of sera from 41 asthmatic patients and 38 specimens 
from nonasthmatic individuals. (34) The asthmatic patients were 
divided into three groups--allergic, infectious, and mixed-type. 
Statistical analysis of the average values for each protein fraction 
revealed a decrease in albumin, increase in alpha-2 and gamma globulin, 
and no significant difference between average values of beta and
alpha-1 globulins.
Tuft in 1956 reported that serum paper electrophoresis examina­
tions of 121 children showed lowered albumin and an elevated alpha-2 
and gamma globulin. (35) Patients who did not have an acute asthmatic 
episode for at least 31 days showed changes limited to the albumin and 
gamma globulin fractions. Steroid therapy had these effects on the 
electrophoretic pattern: an increase in the albumin and alpha-1
globulin levels; no effect on the previously elevated alpha-2 globulin; 
and a decrease in the gamma globulin levels toward normal.
In 1958 Stroh and Eriksen reviewed the serum protein patterns on 
54 patients (adults and children) with a history of infection or 
suffering from either asthma or other allergic conditions. (36) These 
patterns were compared with those obtained from 22 healthy individuals 
of comparable ages. The patients frequently showed an increase in
21
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alpha-1 and alpha-2 globulins and a decrease in albumin. These changes 
appeared to be associated with infections and other general pathologic 
processes, rather than allergic disorder per se. Although changes in 
beta and gamma globulin were occasionally observed, they were not 
statistically significant. Stroh and Eriksen confirmed the findings of 
Cooke et al. that serum protein electrophoretic changes ordinarily were 
not specific in allergic diseases.
Dees and Grunt in i960 found no characteristic serum protein 
changes in a controlled study involving 283 allergic children. (37) 
Again, their conclusions were similar to those of Cooke et al., and 
Stroh and Eriksen.
Vaccarezza in i960 studied serum electrophoretic patterns of forty 
patients with respiratory allergies. (38) Thirty patients of this 
group were considered to be the purely allergic type; ten patients had 
superimposed sinal or bronchial infection. In the purely allergic 
patients, there were no statistically significant changes in the serum 
albumin pattern. A nonsignificant diminution of the albumin level was 
found in 40 per cent of the cases in the infected group. There was a 
marked and constant rise of the alpha-1 globulin in both the purely 
allergic and the infectious groups. The beta globulin was found to 
have increased in 46 per cent of purely allergic patients and "JO per 
cent of the infected group. In both instances, statistical analysis 
showed that the changes were highly significant. There was no notice­
able change in the gamma globulin in the purely allergic patients, 
but a 40 per cent increase was observed in the infectious group of 
asthmatics.
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No attempt will be made to review in detail the voluminous 
literature discussing the use of serum electrophoretic techniques in 
the various diseases. Gutman has summarized almost all of the impor­
tant findings in a review of the results obtained with the moving 
boundary method. (39) Other studies include Luetscher (40) and Fisher 
(4l) (reviews); Lever (42) (emphasizes dermatologic conditions); Flynn 
(1+3) (qualitative estimation of abnormalities in paper electrophoretic 
patterns); Ko'iw et al. (44), Paton et al. (45)» and Macheboeuf et al.
(k6) (paper electrophoresis); Coryell et al. (47) (pregnancy); Arends et 
(48) (Hodgkin’s disease and lymphoma); Bundles et al. (49)
(leukemia); Ropes et al. (50) and Hunt (5l) (rheumatoid arthritis);
Squire (52), Fisher et al. (53), and Stickler et al. (54) (nephrotic 
syndrome); Mahaux and Koiw (55) (myxedema); Bruton (56) (agammaglobul­
inemia); Osserman and Lawlor (57) (multiple myeloma); Wilson and 
Lubschez (58) (rheumatic fever); Satoskar et al. (59) (hepatitis);
Stauber (60) (parasitology); and Kay (6l) (paper electrophoresis in the 
differential diagnosis of ascites).
Finally, Ogryzlo et al. studied one hundred normal subjects as 
well as patients with a wide variety of diseases. (62) They observed 
that in the normal subjects,the total quantity of the serum proteins and 
the concentration of the various globulin components usually remain 
fairly constant within a relatively narrow range. Significant deviations 
from the normal values have not been consistent with continued good 
health. As mentioned earlier, the most common change in the serum 
proteins during the course of various diseases is the reversal of 
albumin/globulin ratio. HyperglobulinemLa associated with hypergamma­
globulinemia may be observed in a variety of diseases. Table VIII,
derived from the article by Gross et al» (63)* shows the various 
conditions in which hypergammaglobulinemia has been noted.
TABLE VIII
CONDITIONS IN WHICH HfPERG AMMAGLQBUUNEMLA HAS BEEN NOTED*
I. INFECTIONS
A. Bacterial
1. Streptococcal, especially in subacute bacterial endo­
carditis, rheumatic fever and acute glomerulonephritis
2. Severe staphylococcal infections
3. Advanced tuberculosis, pulmonary and extrapulmonary
4. Lepromatous leprosy
B. Spirochetal
1 . Syphilis (all 3 stages)
C. Viral
1. Lymphogranuloma venereum**
2. Infectious mononucleosis
3. Psittacosis
D. Rickettsial 
1. Typhus
E. Fungal
1. Histoplasmosis
F. Protozoal
1. Kala-azar**
2. American mucocutaneous leishmaniasis
3. Malaria
G . Helminthic
1. Visceral larva migrans (toxicara canis or eatis)**
2. Trichinosis
H. Chronic infection** of nonspecific etiology
II. HYPERIMMUNIZATION**
III. LIVER DISEASE
A. Portal cirrhosis**
1. Laennec1s cirrhosis
2. Postnecrotic cirrhosis
B. Acute viral hepatitis
C. Toxic hepatitis (such as that from arsenic)
p. Chronic liver disease in young women withextreme hypergamma­
globulinemia I "lupoid hepatitis'*)**
E. Cholangiolitic hepatitis
F. Biliary cirrhosis (late)
IV. SEVERE MALNUTRITION
A. Kwashiorkor
B. Nutritional-recovery syndrome**
V. NEOPLASMS
A. Multiple myeloma**
B. Leukemia (monocytic, chronic myelogenous and chronic 
lymphatic)
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TABLE VIII (Cont*d)
C. Lymphomas
1. Hodgkin* s disease
2. Lymphosareoma
3. Reticulum-cell sarcoma
D. Primary carcinoma and sarcoma, with or without metastases
VI. PARAIROTEENEMIAS AND DYSIROTEINEMIAS 
' A. Macroglobulinemia**
B. Cryoglobulinemia**-
C. Benign hyperglobulinemic purpura**
D. Amyloidosis
VII. DISEASES POSSIBLY ASSOCIATED WITH HYPERSENSITIVITY
A. Connective-tissue diseases ("collagen" diseases)
1. Disseminated lupus erythematosus**
2. Scleroderma**
3. Rheumatic fever
h. Rheumatoid arthritis
5. Ankylosing spondylitis
6. Periarteritis nodosa
7. Sjogren’s syndrome
B. Others
1. Serum sickness
2. Acquired immune hemolytic anemia
3. Autoimmune thyroiditis } Hashimoto’s disease
4. Erythema nodosum
VIII. GRANULOMAS
A, Sarcoidosis**
B. Chronic Beryllium poisoning
IX. DERMATOLOGIC DISORDERS
A. Pemphigus vulgaris (late)
B. Extensive dermatitis Tsuch as exfoliative dermatitis)
C. Burns
* Gross, P.A.M. et al., New Engl. J. Med., 260:121-125, 1959*
** Often associated with striking elevations of gamma-gldbulin 
fraction.
DISCUSSION
Changes in the serum proteins may he seen in many diseases. In 
most instances, there is a decrease in albumin concentration and an 
increase in the globulins. This disturbance in the serum proteins is 
generally known as alteration in the A/G ratio; the standards usually 
accepted are those determined by the chemical precipitation technique.
Infection is one of the most important conditions giving rise 
to increased serum globulin levels. Initially, acute infections may 
cause a rise in the alpha globulin and a fall in the serum albumin. 
(64) If the infection persists or produces a local lesion (abscess 
or endocarditic focus), the rise in the gamma globulin level occurs 
following the absorption of the antigenic and breakdown products. (63) 
This view is supported by the findings presented in this study. 
High gamxsLglobulin levels were recorded in the cases of active and
inactive pulmonary tuberculosis, chronic bronchitis, bronchiectasis, 
and asthma associated with repeated respiratory infections. Gamma 
globulin levels were within normal limits in two groups of patients, 
namely, those who had only allergic asthma and the so-called "mixed 
asthma" which had both infectious and allergic components.
It is important to realize, however, that these changes in 
garana globulin levels are somewhat nonspecific. Similarly, in the 
chest diseases described, the increase of serum gamma globulin levels 
is nondiagnostic, and at best warns the observer that something is
wrong. A final diagnosis can be made only with the help of other 
laboratory aids and clinical judgment.
It is known that patients with agammaglobulinemia are unable to 
synthesize antibodies in response to specific antigens. In contrast, 
certain patients with multiple myeloma may not produce detectable 
antibodies following similar stress even though the gamma globulin 
(prcfcably abnormal) may be present in normal or increased quantities. 
Although the quantitative measurements of gamma globulin in agamma­
globulinemia and multiple myeloma are diametric opposites (absent in 
one and increased in the other), both conditions have in common a 
profound reduction in their antibody responses. (65)
Recently, Hammack et al. described four cases of repeated pneumo­
coccal infections in which the serum electrophoretic patterns showed 
one or more discrete homogenous peaks characteristic of myeloma* (66) 
These patients also failed to produce an adequate response to typhoid 
antigen. On follow-up, one case died of plasma cell leukemia.
Autopsy findings confirmed the diagnosis, but revealed no evidence 
of myeloma.
They studied four more such cases: one of these patients died
of nocardia infection, and an autopsy showed multiple abscesses, 
particularly in the brain; another patient was found to have miliary 
tuberculosis at the time of autopsy. Originally, Hammack and others 
felt that the increased susceptibility of these patients to infection 
was limited only to those caused by the pneumococcus; later they 
noted a decreased host-resistance to other types of infections, 
including bacterial, tuberculous, and fungal. There was, however, no 
evidence of increased susceptibility to viral disorders. (67)
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Smith studied thirteen individuals who did not have a myeloma 
but whose serum electrophoretic patterns were characterized by the 
presence of an abnormally well-defined globulin. (68) He applied the 
term "non-myelomatous paraproteinemia" to this disorder. Clinical 
and chemical studies were undertaken to assess the significance of 
such globulins. Same of these individuals were clinically weHj 
others had diseases such as angina pectoris, tertiary syphilis, 
microcytic anemia, or chronic pulmonary infections. In some others 
an unusual incidence of chronic pulmonary diseases was associated 
with the presence of a macrogldbulin or a cold precipitable globulin 
(cryoglobulin)•
Owen and Rider also described four patients whose serum electro-I
phoretic patterns showed discrete globulin peaks without any other 
evidence of myeloma. (69) Two of these patients had repeated 
episodes of pneumonia. Since all of these cases were unrelated to 
classic myeloma, Hammack and associates suggested a new term, 
"dysgammaglcbulinemia syndrome." This term implies a disturbed 
function of the gamma globulin moiety, manifested clinically by 
repeated infections.
Since the quantitative measurement of gamma globulin offered no 
explanation for the increased susceptibility to infection an attempt 
was made by the present author to study the antibody response in 
some patients suffering from repeated respiratory infections. As 
tuberculosis and allergic asthma can be treated with specific therapy, 
the phase of the study herein described included only the patients 
suffering from a difficult-to-treat disease, chronic bronchitis.
Six patients with chronic bronchitis and histories in common
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of repeated respiratory infections were selected for an immunological 
study. Three of these had elevated serum gamma globulin levels, and 
the remaining three had serum gamma globulin levels in the normal 
range. To these, three controls were added. All nine individuals 
were immunized, once each week for three weeks, with typhoid-para­
typhoid vaccine. Agglutination tests, total proteins, and serum 
electrophoretic studies were done immediately before and three weeks 
after the course of iinniuBization#
Table IX shows the data collected on the three controls. All 
three control subjects showed a good response in 0 and H agglutina­
tion titers.
The same finding was obtained in the three patients with chronic 
bronchitis and elevated gamma glcbulin levels. (Table X)
Of the three patients in the third group (with chronic bronchitis 
and normal gamma globulin levels), one patient failed to respond to 
both the H and 0 antigen. The second responded to the H antigen but 
not to the 0 antigen. The third patient gave a normal response.
(Table XI)
In contrast with the results obtained by Hammack et al., the 
patients belonging to the second group (history of repeated respira­
tory infections and high gamma globulin levels) showed a fairly adequate 
antibody response to the typhoid antigen. However, one patient 
belonging to the third group (with chronic bronchitis but normal gamma 
globulin level) failed to respond to the typhoid antigen. Unfortun­
ately, this patient could not be restudied before he left the hospital.
In cases of chronic lymphatic leukemia (70,7l)* Hodgkin*s disease 
and other lymphomas (72,73), failure to produce circulating antibodies
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has "been suggested as a major weakness in the host*s resistance to 
"bacterial infection. Silver et al. compared the antibody responses to 
five antigens in ten patients with acute leukemia and in ten normal 
control subjects. (7^) The use of five antigens was based on the 
assumption that there may be a significant difference in the degree 
of response to different antigens within the same individual.
Table XII, as adapted from Silver et al., shows the results. Of the 
group of ten patients with leukemia, three responded to typhoid 
vaccine, two to mumps vaccine, and three to influenza vaccine. In 
contrast, seven control subjects responded to typhoid vaccine, seven 
to mumps vaccine, and eight to influenza vaccine. Of the ten patients 
with leukemia, seven responded with a significant rise after adminis­
tration of diphtheria toxoid, in contrast to a rise in all ten of the 
control subjects. Six patients and seven normal subjects had 
significant titer rises after they had received tetanus toxoid. The 
response to any one antigen did not differ significantly in the two 
groups, and all but one of the patients with acute leukemia responded 
to at least one antigen. However, a significantly poorer response in 
the patients with acute leukemia could be demonstrated by comparing 
the over-all antibody response to all antigens of both groups.
It is possible that the over-all poor antibody response cbserved 
in the cases of lymphatic leukemia may also be present in cases of 
chronic bronchitis. The almost universal response to typhoid vaccine, 
as observed in the series of cases of chronic bronchitis described 
in this, the second phase of the study, suggested the use of more 
than one antigen, including both bacterial and viral materials.
Thus, eleven more patients with chronic bronchitis and varying
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levels of serum gamma globulin were studied along with five control 
subjects. These individuals were challenged, during the third phase 
of the study, with multiple antigens— including diphtheria toxoid, 
staphage lysate, mumps, influenza, and typhoid-paratyphoid vaccines. 
The schedule for these injections is given in Appendix J. Blood 
samples were drawn in order to study the antibody titers immediately 
before and two weeks after the completion of injections. Unfortunately, 
the mumps and diphtheria sera were not stored properly and could not 
be used. Some of the sera for influenza happened to be anticomple- 
mentary and had to be discarded. The only samples that could be 
analyzed were those involving typhoid-paratyphoid, staphage lysate, 
and, to some extent, influenza vaccines. Although inconclusive, 
there did not appear to be any significant difference in the antibody 
responses of the three groups, namely, control, chronic bronchitis 
with high gamma globulin levels, and chronic bronchitis with normal 
gamma globulin levels. (Table XIII)
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TABLE XII
FOURFOLD OR GREATER RISE ON DAY 26 IN PATIENTS WITH LEUKEMIA
AND IN NORMAL SUBJECTS
a t- ■ * m . IndividualSubj. Typhoid Influenza Diphtheria Tetanus gcore
No. H
Pts.
1 0 0 0 + + d
2 0 0 0 0 0 0
3
k
0
0
0
+
0
+
0
+
+
*
1
k
. 5 
6
0
+
0
+
0
0
*
+ +
2
k
7 0 0 + + + 31
8 + 0 0 0 0 1
9 + 0 + + 0 3
10 0 0 0 •fc 0 1
Totals 3 2 3 7 6 21
Control 
Subjs, 
11 
12 
13 
lh
15
16
17
18
19
20
4- 4- 4- + 4- 5
+ * 4? •b 5r*
* 4? 4? + •b 5
4? 0 + 4r 0 3
* 0 •b 4? 0 3
4? 4- 0 4? 0 3j.
4? •fc 0 4? 4- 4
0 0 + -b 4? 3
0 4- 4? 4; •b 4
0 4? •b •fc •b 4
Totals 8 10 39
Adapted from: Silver, R.T. et a!., J. Lab. Clin. Med., 56:638, I960.
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TABLE XIII
AUTIBQDY TITERS IN SERA OF ELEVEN PATIENTS WITH CHRONIC BRONCHITIS AND 
FIVE CONTROLS, BEFORE AND AFTER IMMUNIZATION WITH VARIOUS ANTIGENS
Expressed as reciprocal of highest serum dilution.
Typhoid* Typhoid* Staphage- influenza*** 
H ______  Q „ lysate**________________ , . , Gamma Glob.Subject Gmy1Q0 ^
Control 
Subjs.
S.A.
I.K.
E.K.
W.D.
A.M.
1.29
0.95
1.34
0.75
0.76
Before-After Before-After Before-After Before-After
80
40 160 - 160 1600 - 800
80 160 - 160 400 - 1600
40 160 - 640 1600 - 1600
80 <10 - 40 800 - 1600
80 40 - 160 200 - 400
16 - 16 
8 - 1 6  
AC - AC 
AC - 8
Not done
Patients
J.D.
D.D.
F.A. 
M.W. 
W.F.
0.K.
1.E.
G.K.
E.V. 
A.S. 
L.P.
1.67 
1.62 
2 .46
1.95
0.58
0.81
0.96
1.03
0.76
0.81
1.29
<10 640 80 mm 160 1600 - 1600 64 - 128
<L0 80 40 mm 160 1600 - 1600 16 - 32
<10 40 10 mm 20 3200 1600 8 - 8
20 mm 80 160 mm 320 1600 - 1600 Not done
<L0 <L0 10 mm 40 400 - 800 Not done
<10 mm 40 20 mm 40 800 - 800 8 - 6 4
<10 mm <10 20 mm 40 800 - 1600 Not done
10 mm 40 20 mm 1280 800 - 800 AC - AC
<10 10 160 mm 320 800 - 1600 Not done
80 40 160 mm 160 800 - 800 Not done
<10 - 40 160 - 160 1600 - 800 AC - AC
AC = anti-complementary.
* Lederle Laboratories, N. Y., Diagnostic Agents for Clinical and 
Laboratory Use, p. 35*
** Boger, W.P., Frankel, J.W., and Gavin, J.J. Detection and titration 
of staphylococcus aureus agglutinin in serum. Proc. Soc. Exp. Biolo 
and Med., 104:b39, 1980.
*** The author wishes to express grateful acknowledgment to the Micro­
biology Division, U.S. Army Medical Research and Nutrition 
Laboratory, Fitzsimons General Hospital, Denver 30, Colorado, for 
doing these studies.
In the first part of this study, the serum electrophoretic 
patterns were observed in 295 adults. They were divided into eight 
groups: Active pulmonary tuberculosis, 135; inactive pulmonary
tuberculosis, 34; chronic bronchitis, 14; bronchiectasis, 12; infec­
tious asthma, 10; allergic asthma, 20; and mixed-type asthma, 29. 
Forty-one subjects with no histories of known chest disease and with 
normal chest x-ray films were used as controls. The T-test for 
unpaired variates was used to evaluate the difference between each 
of the seven disease groups and the control group.
A statistically significant decrease of serum total proteins 
was observed in the cases of mixed-type bronchial asthma when this 
group was compared with the control group. There was a borderline 
decrease of serum total proteins in the patients with chronic 
bronchitis. No significant changes were noted in patients belonging 
to the other groups studied.
When compared with the control group, there was a significant 
reduction of serum albumin in cases of active and inactive pulmon­
ary tuberculosis and chronic bronchitis, a borderline reduction in 
cases of bronchiectasis and bronchial asthma of the mixed type, and 
no significant difference in cases of bronchial asthma of the allergic 
and infectious types.
No significant changes were noted in alpha-1, alpha-2, and beta 
globulin levels in any of the groups when comparison was made with
SUMMARY AND CONCLUSIONS
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the control group.
There was a marked rise in the level cf gamma globulin in the 
cases of bronchiectasis; a significant rise in gamma globulin levels 
in the cases of active and inactive pulmonary tuberculosis, chronic 
bronchitis, and asthma of infectious origin. Allergic and mixed-type 
asthma cases had no significant changes in gamma globulin levels.
Another series of six patients with chronic bronchitis (a group 
of three with normal gamma globulin levels, and a second group of 
three with high levels) and three controls were inoculated with 
typhoid-paratyphoid vaccine in order to learn their antibody response. 
Of the group with normal gamma globulin levels and chronic bronchitis, 
one patient failed to give any response at all, either to H or 0 
antigen; the second gave a good response to H antigen, but no response 
to 0 antigen; and the third patient responded normally. The control 
group and the three patients with chronic bronchitis with high gamma 
globulin levels also responded adequately to the typhoid antigen.
Since an individual may respond normally to one antigen and 
poorly to another, it is necessary to study a subject’s response to 
several antigens before making any decisions about the individual's 
antibody response. With this in mind, multiple antigens were given 
to another group of eleven patients with chronic bronchitis, and to 
five control subjects. Although the results were somewhat inconclu­
sive because of certain technical difficulties, none of these 
individuals appeared to display any significant abnormality in his
antibody response.
On the basis of this study, the following conclusions may be 
put forth: l) Different chest diseases which are associated with
40
chronic infections may be accompanied by gamma globulin levels higher 
than normal. However, this rise in the level is nondiagnostic and 
nonspecific. 2) Lack of antibody response does not seem to be of major 
importance in chronic bronchitis patients having histories of repeated 
respiratory infections.
&
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APPENDIX A
THE CONCENTRATIONS CF SERUM PROTEIN FRACTIONS (GM/lOOcc)
IN 135 CASES OF ACTIVE PULMONARY TIBERCUIDSIS
Total Alpha-1 Alpha-2 Beta Gamma
Pt. Sex Age Prot. Album* Glob* Glob. Glob* Glcib.
M.L. F 25
C.M» F 17
J.M. M 2k
M.R. F 22
H.S. F 50
S.C. M 30
M.H. F 39
A.t. F 1+9
S.M. M 19
M.R. F 18
B .B 0 M 51
N.L. F 28
M.L. F 1+8
M.L. F 63
M.L. F 53
E.M. F 18
R.M. M 39
W.N. M 55
F.N. M 1+1+
R.O. M 30
S. P. F 78
M.P. F 1+6
E.P. F 23
J.R* M 1+6
L.R. F 36
J .R. F 25
M.S. F 1*6
M.S. F 3**
J.S. M 1+6
H.S. F 1+5
L.T. M 37
H.U. M 62
A.V. F 1+7
L.W. M 21
C.W. M 28
J.Y. M 32
D.M. F 63
M.S. F 1+9
N.F. F 63
J.M. F 35
W.A. M 55
L.A. F 1+0
M.A. F 58
7.0 3.33
8.1+ 3.16
7.7 5.70
7.2 4.76
7.7 1+.16
7.7 5.20
6.9 3.75
8.1 k.3k
6.6 3.07
8.2 3.*+7
8.5 1+.68
7.0 1+.1+3
7.8 5.18
8.5 6.02
6.6 ^.53
7.3 3.87
7.*i 1+.82
6.7 3.10
6.6 3.33
7.9 1+.51
6.5 2.18
6.7 2.93
7.9 3.80
8.3 3.91
10.5 6.65
7.** 3.53
8.5 5.85
7.1 3.55
7.8 *+.13
7.3 2.72
8.2 3.79
7.2 3.2I+
7.0 1+.21
7.7 3.31
6.2 3.08
7.6 1+.10
7.3 1+.23
6.3 2.87
7.0 3.29
7.2 3*7*+
7.2 2.56
6.6 2.1+7
7.9 3.79
0.17 0.55
0.38 1.08
0.15 0.52
0.20 0.57
0.18 O .63
0.23 0.1+2
0.19 O .56
0.21+ O .58
0.29 1.11+
0.39 1.3*1
0.15 O .85
0.25 0.50
0.18 O .38
0.26 0.67
0.18 O .69
0.22 0.1*8
0.21 0.5I+
0.18 0.7*1
0.27 1.03
0.13 0.1+1+
0.39 0.81
0.28 1.13
0.27 0.88
0.37 1.10
0.1+3 0.99
0.21+ 0.73
0.17 0.55
0.23 0.72
0.22 1.01+
0.39 O .78
0.31+ 0.61
0.21 O .67
0.16 0.31
0.85 1.20
0.27 0.70
O .36 0.82
0.1+1+ 0.80
O.3I+ 0.60
0.31 0.70
0.11+ 0.52
0.1+1 1.27
0.23 0.61
0.31 0.9!+
0.59 1.1+9
2.01 1.76
0.68 0.55
0.86 0.66
1.1+7 1.10
0.81 1.08
0.68 1.70
0.83 1.9*+
1.25 0.1*8
1.23 1.77
0.21 2.55
0.76 1.06
0.84 1.00
0.85 0.67
0.50 0.55
1.00 1.68
0.98 0.83
1.02 1.70
1.10 0.86
0.81 2.09
1.11 2.07
1.21 1.05
O .98 1.86
1.38 1.52
0.86 1.61
0.84 2.05
0.55 1.31
0.72 1.57
1.1+0 1.0*+
0.68 2.75
1.62 1.82
0.91 2.33
0.62 1.52
0.25 2.69
0.77 1.3*+
O .85 1.39
1.10 1.53
1.11 1.37
0.70 1.96
0.32 1.91
1.01 1.77
1.12 1.1+3
1.22 1.1+9
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Appendix A: The Concentrations of Serum Protein Fractions (GM/lOOcc) 
in 135 Cases of Active Pulmonary Tuberculosis (Cont'd)
Total Alpha-1 Alpha-2 Beta Gamma
Ho. Pt. Sex Age Prot. Album. Glob. Glob. Glob. Glob.
44 J.A. F 35 7.26 3.78 0.15 0.52 0.83 1.92
45 R.B. M 43 7.10 4. V7 0.21 0.43 O .87 1.08
46 F.B. M 59 4.4 1.40 0.29 1.11 1.03 O .55
47 I.B. F 28 9.9 ^.69 0*27 0.97 1.^1 2.43
48 C.B. M 42 7.8 3.97 0.28 0.96 0.87 1.70
49 E.B. F 29 7.92 3.92 0.22 0.90 0.90 1.85
50 I.C. F 23 7.50 2.88 0.30 1.14 I .38 1.80
51 H.C. F 33 7.60 5.^0 0.03 0.37 O.65 1.10
52 J.C. M 26 7.^0 4.37 0.23 0.52 0.6l 0.6l
53 G.C. F 56 8.9 4.69 0.31 0.56 0.89 2.40
54 E.C. M 22 6.8 4.25 0.12 0.44 0.75 1.0
55 J.C. M 20 8.1 4.37 0.27 1.02 0.93 1.78
56 M.D. M 51 7.8 4.13 0.21 0.97 0.92 1.47
57 R.D. M 20 7.91 4.14 0.36 0.55 0.91 1.87
58 G.D. F 43 7.^ ^.63 0.20 0.47 0.72 0.87
59 J.F. M 35 7.5 4.43 0.23 0.59 0.86 1.26
60 W.G. M 20 7.4 3.69 0.41 1.07 1.15 O .98
61 D.G. F 55 6.5 3.28 0.21 0/87 0.73 1.28
62 . R.H. M 43 7.1 ^.27 0.31 O.83 0.65 1.04
63 B.H. M 49 7 A  3.57 O .38 1.07 1.00 1.30
64 W.J. M 48 8.0 3.79 0.18 0.71 1.13 2.06
65 H.J. F 24 8.3 4.37 0.23 0.89 0.92 1.88
66 P.J. F 22 7.9 3.71 0.28 1.62 0.88 1.33
67 M.K. M 22 7.3 5.28 0.09 0.39 0.41 1.13
68 J.A. M 45 7.3 3.83 0.12 0.95 1.10 1.37
69 W.A. M 54 7.4 3.47 0.40 0.87 1.07 1.40
70 M.B. F 44 8.6 2.97 0.33 l.1#  1.84 2.18
71 P.B. M 61 7.3 3.53 0.27 0.72 0.83 1.91
72 D.B. M 44 8.4 3.81 0.29 1.10 1.10 2.07
73 J.B. M 43 7.6 2.86 0.34 0.98 1.82 1.59
74 E.B. M 54 7.4 4.46 0.13 0.83 0.73 1.23
75 J.C. M 52 6.9 3.71 0.27 0.58 0.61 1.66
76 J.C. M 32 7.3 3.33 0.30 0.45 0.84 2.20
77 E.C. F 32 7.7 *W97 0.23 0.62 0.77 1.12
78 W.D. M. 53 8.2 *. 3.79 0.34 1.09 1.15 1.84
79 R.D. F 43 8.5 5.37 0.26 0.99 0.73 1.08
80 N.E. M 51 5.7 2.18 0.26 O .92 0.63 1.65
81 W.E. M 33 6.6 3.68 0.19 0.51 0.87 1.32
82 M.F. F 30 7.4 3.69 0.29 0.58 0.83 1.95
83 J.F. M 62 6.8 2.88 0.37 0.81 1.41 1.25
84 P.F. F 31 6.9 3.21 0.24 0.72 0.79 1.90
85 K.G. M 4l 7.6 4.48 0.24 0.84 0.85 1.09
86 L.G. M 48 7.99 3.50 0.36 0.16 2.36 1.61
87 E.G. M 48 8.0 3.13 0.38 1.22 1.18 2.07
88 H.G. M 54 7.2 2.82 0.59 1.07 1.30 1.43
89 H.G. M 4-9 9.4 4.16 0.21 0.68 1.29 3.05
90 A.H. M 48 8.7 4.44 0.29 1.21 1.38 1.42
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Appendix A: The Concentrations of Serum Protein Fractions (GM/lOOcc)
in 135 Cases of Active Pulmonary Tuberculosis (Cont'd)
Total Alpha-1 Alpha-2 Beta Gamma
No. Pt. Sex Age Prot. Album. Glob. Glob. Glob. Glob.
91 J.H. M 51 7.5 4.15 0.32 O .63 0.89 1.42
92 J.J. M 60 8.7 3.78 0.42 1.02 0.77 2.70
93 E« J . F 36 1 '^ 3.79 0.22 0.68 0.79 1.5994 R.K. M 27 7.4 3.71 0.37 0.98 1.39 0.92
95 A.K. M 49 8.3 4.11 0.24 1.16 1.35 1.70
96 L.K. M 50 7.8 ^.59 0.21 0.50 0.93 1.44
97 D.L. F 47 7.8 3.20 0.31 0.62 1.01 2.73
98 A.M. F 60 6.6 3.22 0.24 0.97 1.03 1.06
99 M.M. M 49 7.4 3.88 0.27 1.06 0.70 1.39
100 M.M. F 3^ 8.1 3.13 0.4l 1.11 1.53 1.84
101 H.M. M 38 8.6 4.54 0.33 0.81 O .89 2.00
102 M.M. M 48 6.3 1.52 0.23 0.93 0.52 3.04
103 M.M. F 36 6.6 1.35 0.23 O .65 0.65 1.72
104 E.M. F 4l 7.7 2.53 0.44 O .85 1.16 2.53
105 J.M. M 52 5.8 3.5^ 0.37 1.00 1.03 0.86
106 T.M. M 40 7.2 3.96 0.4 0.68 O .89 1.45
107 C.N. F 51 6.8 3.45 0.36 1108 0.72 1.15
108 F.N. F 49 7.1 2.84 0.28 0.81 0.97 2.02
109 D.P. M 45 7.7 4.08 0.21 O .92 0.95 1.50
110 A.P. F 33 7.^ 4.32 0.17 0.75 O.85 1.32
111 M.P. F 42 7.3 3.80 0.18 0.74 0.93 1.56
112 C.R. M 57 7.3 3.30 0.39 1.14 1.11 1.28
113 O.R. F 19 7.3 2.57 0.36 1.28 0.80 2.25
1Ik M.S. F 4l 7.1 4.86 0.19 0.42 O .65 0.96
115 E.S. F 38. 7.3 3.^3 O .36 O.85 0.82 1.82
116 A.S. M 52 7.6 4.38 0.11 0.80 1.38 0.80
117 H.S. M 49 8.0 4.02 0.37 0.82 1.03 1.78
118 J.S. M 54 7.5 3.18 0.29 0.59 0.62 2.82
119 E.S. F 45 6.4 4.42 0.14 O .51 O .78 0.55
120 P.S. F 40 7.2 4.18 0.19 0.58 0.87 1.32
121 A.S. M 24 8.3 3.06 0.35 O.87 0.66 0.30
122 B.S. F 4l 7.7 2.86 O .36 O.85 1.10 2.45
123 I.T. F 38 8.7 3.38 0.34 i . n 1.52 2.00
124 S.T. M 29 7.6 5.27 0.25 0.38 0.71 1.04
125 R.T. M 67 7.2 4.03 0.28 0.82 0.60 1.37
126 V.T. M 31 7.1 3.93 0.22 0.55 0.94 1.30
127 J.T. M 65 6.6 3.80 0.63 0.69 1.49
128 E.V, M 56 8.6 3.71 0.20 0.72 1.73 2.21
129 M.Y. F 31 7.3 3.50 0.30 0.72 0.96 1.74
130 M.C. F 45 7.9 3.33 0.32 0.65 1.16 2.39
131 J.J. M 32 7.2 3.28 0.22 0.57 1.04 1.99
132 C.B. F 26 6.8 4.32 0.22 0.69 0.67 0.89
133 D.K. F 30 7.15 *.75 0.29 0.44 0.56 1.11
134 J.H. M 20 8.0 3.30 0.44 1.18 1.18 1.80
135 E.R. F 29 7.7 3.97 0.22 0.62 1.11 1.77
Mean 7.51 3.28 0.20 0.79 0*96 1*57
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APPENDIX B
THE CONCENTRATION OF SERUM PROTEIN FRACTIONS (GM/lOOcc)
IN 3*1 CASES CF INACTIVE PULMONARY TUBERCULOSIS
Total Alpha-1 Alpha-2 Beta Gamma
pt. Sex Age Prot. Album* Glob. Glob« Glob. Glob*
W.L. M 68 6.7 3.48
P.R. M 2b 7.5 2.85
E.L* F 33 8.1 3.51*
M.D. F 20 7.2 3.48
H.L. F 33 6.75 3.14
J.Y. F 2b 7.2 2.87
L.W. F 38 6.7 3.76
F.C. F 30 8.4 5.09
T.E. F 17 6.8 3.20
A.M. M 33 8.0 4.55
w.s. M 58 8.0 3.72
A.K. F 27 6.9 3.73
D.M. M 23 8.0 4.29
M.H. F b6 7.0 3.61
S.K. M 52 7.5 3.47
H.S. M 27 6.8 3.65
J.O. F 28 7.6 3.67
G .A. M 17 8.0 3.40
W.B. M 57 7.6 3.78
T.K. M 37 7.7 3.57
M.D. F b6 7.1 3.81
L.L. F 3k 6.9 3.55
R.S. M 29 6.9 3.95
P.J. F 25 7.2 3.78
D.C. M 3^ 6.65 3.59
R.H. F 40 6.70 3.30
T.C. F 65 7.2 4.4
S.F. M 54 7.8 3.2
G.H. M 40 8.0 3.86
L.L. M 49 7.6 2.35
A.S. M 51 7.5 3.72
L.T. F 39 7.0 3.72
J.E. F 26 8.3 3.90
R.T. M 43 8.0 3.55
0.23 0.78 1.01 1.21
0.41 0.98 1.37 1.15
0.26 0.88 1.25 2.10
0.44 0.57 0.95 1.71
0.20 1.07 1.11 1.23
0.40 0.96 1.43 1.53
0.21 O .70 0.76 1.25
0.21 0.43 1.11 1.54
0.07 O .58 0.65 2.21
0.38 0.6l 0.56 1.90
0.18 0.81 1.25 2.02
0.32 0.75 0.77 1.26
0.22 0.59 1.58 1.19
0.20 0.57 1.01 1.61
0.35 0.92 1.31 1.44
0.24 0.54 0.79 1.58
0.34 0.40 0.97 2.04
0.24 1.02 1.70 1.64
0.27 1.07 1.21 1.64
0.l4 1.00 1.35 1.64
O .23 0.65 1.28 1.16
0.19 0.53 0.82 1.74
0.09 0.76 O .76 1.26
0.22 0.78 0.78 1.63
0.20 0.53 1.06 1.06
0.24 0.72 1.13 1.31
0.31 0.74 1.17 1.05
0.55 0.45 1.15 2.45
0.33 0.73 1.01 2.07
0.27 0.87 1.72 1.85
0.35 0.77 O .98 1.62
0.27 0.90 0.62 1.43
0.17 0.54 1.74 1.79
0.13 0.74 0.80 2.85
MEAN 7.39 3.63 0.26 O .73 1.10 1.62
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APPENDIX C
THE CONCENTRATIONS OF SERUM PROTEIN FRACTIONS (GM/lOOML.)
IN Ik CASES OF CHRONIC BRONCHITIS
Pt. Sex Age
Total
Prot. Album,
A.G. M. 56 7.5 4.06
C.M. F 57 5.9 3.33
D.P. M 2k 8.0 3.27
E.W. F 6k 5.8 2.51
D.C. F 50 5.5 2.21
O.K. F 26 6.8 3.07
N.M. F 37 7.9 3.08
G.P, M 52 7.0 3.07
P.N. F 16 8.5 3.26
B. M 56 6.6 3.00
D.M. F 45 6.8 2.96
M.M. F 15 8.8 3.26
C.B. M 53 7.9 4.12
F.M. M 57 6.7 2.33
Alpha-1 Alpha-2 Beta Gamma 
Glob. Glob. Glob. Glob.
0.29 0.69 0.99 1.42
0.11 0.68 1.01 0.74
0.21 1.10 1.53 1.85
0.23 0.53 0.73 1.78
0.29 0.60 1.17 1.05
0.39 1.45 0.78 1.03
0.35 1.28 1.15 1.99
0.42 1.07 0.94 1.49
O .38 0.97 0.89 3.01
0.13 O .69 0.74 1.68
0.29 0.95 1.17 1.42
O .36 1.37 1.21 2.6l
0.14 O .76 1.09 I .90
0.33 1.13 1.39 1.50
MEAN 7.12 3.11 0.28 0.95 1.06 1.68
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THE CONCENTRATIONS CF SERUM PROTEIN FRACTIONS (GM/lOOML.) 
IN 12 CASES CF BRONCHIECTASIS
APPENDIX D
No. Pt. Sex Age
Total
Prot. Album.
Alpha-1 
-Glob.
Alpha-2
Glob.
Beta
Glob.
Gamma
Glob.
1 G.B. F 72 7.5 2.55 0.l4 0.43 1.08 3.38
2 R.B. M 6l 6.9 2.77 0.19 1.45 0.94 1.50
3 M.B. F 26 7 A 3.12 0.25 0.81 0.75 2.47
4 J.K. M 70 8.0 4.29 0.32 0.90 1.34 1.31
5 B.R. F 40 8.35 2.76 0.31 0.69 2.10 2.76
6 C.S. M 42 7.6 3.38 0.35 0.82 0.74 2.25
7 G.S. M 45 6.9 4.26 0.26 0.66 0.86 0.92
8 E.Z. F 37 7.6 4.62 0.15 0.45 0.90 1.49
9 L.P. F 48 6.1 1.93 O .32 1.00 0.90 1.67
10 M.B. F 47 7.5 4.31 0.21 0.74 0.74 1.58
11 P.H. M 47 7.0 3.02 0.31 0.92 0.78 1.97
12 O.S. M 52 7.1 3.59 0.13 0.47 O.83 2.03
MEAN 7.33 3«38 0*24 O.78 1.00 1.94
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APPENDIX E
THE CONCENTRATIONS OF SERUM PROTEIN FRACTIONS (GM/lOOML.) 
IN 10 CASES (F INFECTIOUS ASTHMA
Total Alpha-1 Alpha-2 Beta Gamma
No. Pt. Sex Age Prot. Album. Glob. Glob. Gleb. Glob.
1 I.B. F 52 8.5 3.51 0.40 1.10 1.19 2.38
2 W.B. M 16 6.7 3.45 0.22 0.72 O .85 1.43
3 D.C. M 43 8.0 4.55 0.20 0.59 1.04 1.58
k E.C. F 1*5 6.6 3.59 0.21 0.74 1.06 1.00
5 G.D. F 47 7.8 3.92 0.25 0.55 1.12 1.97
6 P.S. F 19 6.9 2.92 0.22 0.82 1.14 1.77
7 A. S. F 47 7.5 3.65 0.10 O .38 1.65 1.63
8 J.V. M 15 7.8 4.15 0.43 O.85 0.82 1.55
9 G.W. F 27 6.8 2.28 0.38 O .98 0.87 2.28
10 D.A. F 16 6.9 3.45 0.17 0.57 1.17 1.4l
MEAN 7.35 3.55 0.26 0.73 1.09 1.70
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APPENDIX F
THE CONCENTRATIONS OF SERUM PROTEIN FRACTIONS (GM/lOO Ml)
IN 20 CASES CF ALLERGIC ASTHMA
Total Alpha-1 Alpha-2 Beta Gamma
No. Pt. Sex Age Prot. Album. Glob. Glob. Glob. Glob.
1 L.A. M 26 8.0 k.66 0.14 0.61 0.94 1.74
2 J.A. F 15 6.05 3.69 0.16 0.53 0.48 1.19
3 P.B. F 18 7.95 3*64 0.39 1.28 1.40 1.244 A.B. M 18 1.6k 3.91 0.11 1.19 I .07 1.51
5 A.B. F 19 7.90 4.19 0.19 0.95 O .87 1.54
6 L.B. F 16 7.26 3.53 0.20 1.08 1.08 1.32
7 L.B . F 36 8.25 3.76 0.54 0.27 1.54 2.18
8 J *C» M 16 7.10 4.57 0.23 O.67 0.6l 1.02
9 A.C. M 17 7.35 5.15 0.22 O .54 0.46 0.99
10 J.G. F 20 7.2 3.76 0.29 0.96 1.06 1.11
11 B.G. F 57 8.2 3.28 0.33 1.44 1.58 1.55
12 R.H. M 35 8.6 4.37 0.21 0.90 1.46 1.55
13 J.K. M 19 6.6 3.98 0.24 0.4l 0.62 1.35
14 B.M. M 38 6.9 3.57 0.4l 0.56 1.17 1.17
15 J.M. F 17 8.9 4.4l 0.46 1.42 1.14 1.42
16 L.S. M 19 6.60 3.47 0.35 O .63 1.16 1.00
17 F.S. F 15 6. k 4.10 O .23 0.29 0.84 0.94
18 T.S. M 18 6.2 3.91 0.19 0.61 0.76 0.71
19 H.S. M 17 8.8 4.70 0.43 1.16 1.12 1.60
20 C.H. F 15 7.10 3.02 O .32 1.18 1.33 1.28
MEAN 7.45 3.98 0.28 O .83 1.03 1.32
No.
1
2
3
1*
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7
8
9
10
11
12
13
Ik
15
16
17
18
19
20
21
22
23
2k
25
26
27
28
29
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APPENDIX G
THE CONCENTRATIONS OF SERUM PROTEIN FRACTIONS (GM/lOO ML)
IN 29 CASES OF MIXED TXPE OF ASTHMA
Pt. Sex Age
Total
Prot. Album.
Alpha-1 
Glob.
Alpha-2 
Glob.
Beta
Glob.
Gamma,
Glob.
B.A. F 39 5.5 2.83 0.21 0.71 0.52 1.23
H.B. M 6l 7.1 1*.15 0.25 0.80 O .58 1.29
M.C. M 16 8.1* 1*.26 0.16 0.82 0.91 2.18
M.C. F 28 7.1 l*.l8 0.21* 0.77 9.77 1.01
H.F. F 59 7.15 3.07 0.29 0.11 1.22 1.52
A.G. F 52 7.9 3.79 0.28 0.85 1.1*2 1.1*7
R.G. M 53 6.6 3.25 0.26 0.81 1.07 1.18
S.G. F 52 6.2 3.50 0.30 0.86 0.92 0.6l
S.G. F 17 8.0 *•79 0.31 0.81 0.81* 1.20
V.H. F 1+7 6.3 3.79 0.14 0.86 O.7I* 0.66
M.H. F 52 8.1 3.71 0.1*2 1.17 1.36 1.1*6
M.I. F 18 7.1 3.52 0.20 0.99 1.33 1.06
M.L. F hi 6.1* 3.1*1* 0.32 0.72 1.13 0.75
A.L. M 55 6.9 3.86 0.37 0.68 0.99 0.93
B.M. F 23 7.5 3.92 0.37 1.01 1.05 1.11
M.N. F 18 7.55 3.52 0.21 0.91 1.1*1 1.37
O.N. M 1*1 7.5 3.87 0.19 0.66 0.99 1.75
M.O. F 20 7.28 3.93 0.13 0.62 0.81 1.63
V.P. F 1*2 7.3 5.11 0.19 0.1*8 0.55 0.96
D.R. F 16 7.15 3.93 0.35 0.6l 0.73 1.51*
w.s. F 67 6.3 3.63 0.15 0.77 0.57 1.08
M.S. F 19 5.8 2.1*7 O.3I* 0.99 1.21* 0.59
E.S. F 1*9 6.5 3.78 0.20 0.66 0.79 0.96
E.S. F 51* 6.3 2.9k 0.16 0.88 1.05 1.22
H.T. M 61 8.0 1**93 0.31 0.59 0.69 1.30
T.W, F 51* 6.8 2.97 0.18. 0.78 1.37 I . 5I*
J.W. M 55 6.6 3.16 0.19 0.59 1.00 1.66
H.W. M 51* 7.2 1*.03 0.18 O.72 0.99 1.22
G.Y. M 19 8.0 3.51* 0.19 0.59 1.1*5 2.18
MEAN 7.06 3.72 0.2** 0.75 O .98 1.26
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APPENDIX H
THE CONCENTRATIONS OF SERUM PROTEIN FRACTIONS IN 4l ''CONTROLS'
No. Pfc. Sex Age
Total
Prot. Album.
Alpha-1 
Glob.
Alpha-2 
Glob.
Beta
Glob.
Gamma
Glob.
1 T.M. M 31 9.1 4.28 0.33 0.80 1.42 2.22
2 J. M 35 9.0 4.72 0.28 0.64 1.07 2.23
3 D.L. M 35 9.1 5.05 0.21 0.96 1.26 1.56
4 S.P. M 36 8.6 4.16 0.4l 0.86 1.44 1.72
5 H.B. M 35 9.4 4.37 0.45 1.30 1.75 1.47
6 D. M 42 8.1 3.99 0.34 0.85 1.34 1.6l
7 E. M 50 7.5 4.47 O .25 0.78 1.00 1.03
8 R. M 28 8.4 5.44 0.27 0.70 0.72 1.33
9 J.B. M 30 8.6 5.16 O .31 0.45 1.17 1.58
10 J.K. F 25 8.6 4.34 0.21 0.49 1.69 1.79
11 G. F 24 7.5 3.75 0.30 0.84 0.84 1.80
12 Y. F 23 7.6 4.15 0.31 I .09 1.04 1.35
13 J.E. F 22 7.1 2.73 0.37 0.55 1.67 1.63
14 B. F 29 6.5 3.12 0.32 0.94 1.11 0.90
15 L.S. F 40 6.75 2.63 0.4l 1.00 1.22 1.55
16 S. M 38 7.4 3.18 0.27 1.38 1.27 1.22
17 J. F 36 6.9 4.38 0.10 0.58 0.94 0.92
18 M. F 49 7.5 4.01 0.30 0.86 0.86 1.43
19 C. M 51 7.3 4.22 O .38 0.62 0.86 1.27
20 S.D. F 42 7.0 4.31 0.18 0.47 1.01 1.04
21 M.M. M 40 7.8 4.26 0.15 O.72 O .72 1.95
22 V.T. M 32 7.7 4.72 0.31 O .71 0.72 1.18
23 J.L. M 31 6.56 4.28 0.22 0.41 0.64 1.01
24 P.G. M 35 8.0 5.42 0.17 0.66 0.62 1.10
25 M.R. F 42 7.8 5.43 0.23 0.70 O .56 0.85
26 M.K. F 26 8.0 5.22 0.22 0.78 0.66 1.10
27 J.M. F 24 7.7 4.85 0.29 0.43 0.77 1.36
28 C.H, F 2? 8.0 5.36 0.14 0.53 0.82 1.1429 I.N. F 24 8.28 4.50 0.34 0.62 0.95 1.88
30 M.S. F 30 7.28 4.30 0.40 0.34 I .03 1.20
31 M.M. F 23 7.44 4.88 0.18 0.49 0.76 1.13
32 D.H. F 23 7.5 3.94 O .38 0.94 0.79 1.43
33 S. M 43 7.5 4.40 0.32 0.86 1.25 1.46
34 w. F 30 6.8 4.11 0.10 0.78 0.92 O .91
35 J. M 50 8.0 4.82 0.22 0.90 1.18 1.08
3 6 F. M 32 7.1 3.41 0.40 0.55 1.53 1.06
37 L.B. F 31 7.0 4.21 0.21 0,54 1.02 1.04
38 R.K. M 34 6.75 3.98 0.41 1.01 0.68 0.82
39 c. M 32 6.5 3.25 0.26 0.94 1.16 0.77
40 J. M 55 8.6 5.16 0.30 0.46 1.26 1.51
41 S.C. M 58 7.0 4.38 0.21 0.39 0.91 1.03
MEAN 1.69 ^33 0.28 0.73 1.04 1.33
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APPENDIX J 
IMMUNIZATION SCHEDULE
Study Day Antigens Dose
0 (Blood sample drawn)
1 Staphage lysate 0.05 ml. S.C.
Mumps vaccine 1.0 ml. S. Co
Diphtheria toxoid 0.05 ml. I.M.
2 Influenza vaccine 1.0 ml. I.M.
Typhoid-paratyphoid vaccine 0.5 ml. S.C.
1+ Staphage lysate 0.1 ml. S.C.
8 Mumps vaccine 1.0 ml. S.C.
Staphage lysate 0.1 ml. S.C.
9 Typhoid-paratyphoid vaccine 0.5 ml. S.C.
12 Staphage lysate 0.3 ml. S.C.
16 Staphage lysate o.i* ml* S.C.
Typhoid-paratyphoid vaccine 0.5 ml. S.C.
18 Diphtheria toxoid 0.5 ml. I.M.
20 Staphage lysate 0.5 ml. S.C.
32 (Blood sample drawn)
S.C. = administered subcutaneously 
I.M. = administered intramuscularly
